Erie Indemnity Cl A saw its IBD SmartSelect Composite Rating rise to 96 Tuesday, up from 94 the day before.
The new score means the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria. The top-performing stocks tend to have a 95 or better grade as they start a significant move so be sure to keep that in mind when looking for the best stocks to buy and watch.
Erie Indemnity Cl A broke out earlier, but has fallen back below the prior 411.72 entry from a double bottom. If a stock you're tracking clears a buy point then declines 7% or more below the original entry price, it's considered a failed base. Wait for the stock to set up and breakout from a new base and buy point.
Looking For The Best Stocks To Buy And Watch? Start Here
The stock has a 94 EPS Rating, which means its recent quarterly and longer-term annual earnings growth tops 94% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
In Q4, the company reported 37% earnings growth. Revenue growth came in at 13%, down from 16% in the prior quarter.
Erie Indemnity Cl A holds the No. 7 rank among its peers in the Insurance-Brokers industry group. Baldwin Insurance Cl A, Ryan Specialty Holdings and Brown & Brown are among the top 5 highly-rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
